Application no. and date | 19752609.8 (espacenet) (Federated) (European Patent Register), 20190730 | Patent/reg. no. and date | DK/EP 3829568, 20230906 | Publication date | 20210609 | Priority no. and date | US 201862713056 P, 20180801 | EP pub. no. and date |
EP 3829568 20210609 | Effective date | | Applicant/owner | Alzheon, Inc., 111 Speen Street Suite 306
Framingham, MA 01701, US | Applicant ref. no. | MCCQ/P76487EP | Inventor | KOCIS, Petr, 111 Speen Street, Suite 306
Framingham, MA 01701, US, HEY, John, 111 Speen Street, Suite 306
Framingham, MA 01701, US, TOLAR, Martin, 111 Speen Street, Suite 306
Framingham, MA 01701, US | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | Opponent | | IPC Class | A61K 31/221 (2006.01) , A61K 31/222 (2006.01) , A61K 31/223 (2006.01) , A61K 31/225 (2006.01) , A61K 31/255 (2006.01) , A61P 25/28 (2006.01) , G01N 33/50 (2006.01) , G01N 33/52 (2006.01) | Title | SULFOPROPANOIC ACID DERIVATIVES FOR TREATING NEURODEGENERATIVE DISORDERS | Int. application no. | US2019044114 | Int. publication no. | WO2020028348 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|